Delivery of active agents from chewing gum for improved remineralization.
Most surrogate measures of caries were developed to test products containing fluoride, typically at relatively high and closely controlled oral concentrations. However, since the primary mechanism for the remineralization of early enamel caries lesions by chewing gum is through stimulation of saliva, delivering Ca and Pi to the demineralized enamel lesion, established methods may lack the sensitivity to detect the additional benefit of an active agent without the strong remineralizing potential of fluoride. Issues related to the release of active agents from the gum matrix, dilution in the saliva, and limited oral retention time, along with taste, safety, regulatory, and cost concerns, impose further limitations. This paper reviews the efficacy of some active agents used in chewing gum for improved remineralization and includes results from in situ testing of calcium-containing gums, including calcium lactate, tetracalcium phosphate/dicalcium phosphate anhydrous, calcium citrate/encapsulated phosphate, and a calcium lactate/sodium phosphate blend. Despite promising in vitro data from these agents, they did not provide consistently superior results from in situ testing. There is a need to develop better predictive in vitro models for chewing gum, as well as improved sensitivity of in situ models to discriminate relatively small amounts of remineralization against a background of high biological variability.
Wm. Wrigley Jr. Company, 1132 West Blackhawk Street, Chicago, IL 60642, USA. michael.dodds@wrigley.com
M W J
MW
Dodds
D
D
Chidichimo
M S
MS
Haas
D000704:Analysis of Variance; D002130:Calcium Phosphates / Q000627:therapeutic use*; D002638:Chewing Gum; D003731:Dental Caries / Q000517:prevention & control*; D003743:Dental Enamel; D003773:Dental Plaque / Q000503:physiopathology*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D012463:Saliva / Q000502:physiology; D014089:Tooth Remineralization / Q000379:methods*; D014993:Xylitol / Q000627:therapeutic use
D002130:Calcium Phosphates; D002638:Chewing Gum; D014993:Xylitol